Rite Aid Corporation (RAD)
|Net Income (ttm)||-635.61M|
|Day's Range||9.03 - 9.66|
|52-Week Range||4.68 - 19.22|
|Price Target||5.61 (-38.3%)|
|Earnings Date||Sep 21, 2022|
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety... [Read more...]
In 2021, Rite Aid's revenue was $24.57 billion, an increase of 2.18% compared to the previous year's $24.04 billion. Losses were -$538.48 million, 492.3% more than in 2020.Financial Statements
According to 10 analysts, the average rating for RAD stock is "Sell." The 12-month stock price forecast is 5.61, which is a decrease of -38.28% from the latest price.
PHILADELPHIA--(BUSINESS WIRE)--It's not too early to schedule your flu shot. Rite Aid (NYSE: RAD) has opened online scheduling for flu shots at its locations including Bartell Drugs in the Pacific North...
Rite Aid (RAD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
The pharmacy chain could still be the target of activist investors.
Source: Michael Gordon / Shutterstock.com Rite Aid (NYSE: RAD ) stock is heading higher on Friday as speculation about activist investors turning the company around spreads online. The latest talk sugge...
PHILADELPHIA--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today published its fourth annual Environmental, Social and Governance (ESG) Report, detailing the company's strategy and progress against goals over ...
PHILADELPHIA & SECAUCUS, N.J.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced it is collaborating with Quest Diagnostics (NYSE: DGX) to provide access to quality, COVID-19 molecular testing (poly...
PHILADELPHIA--(BUSINESS WIRE)--Today, Rite Aid (NYSE: RAD) unveiled its new headquarters in Philadelphia's thriving Navy Yard district. The Rite Aid Collaboration Center, located on the second floor of ...
Elixir Launches Specialty Generic Enhancement that Leads to Thousands in Annual Savings for Plan Sponsors and Members
PHILADELPHIA--(BUSINESS WIRE)--Elixir, a wholly owned subsidiary of Rite Aid (NYSE: RAD), announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June...
Fear of falling tech stocks and crypto is deterring people from buying SQ stock, but savvy investors shouldn't ignore this opportunity. The post Block Stock Traders Are Ignoring the Rite-Aid Collab, but...
CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) announced today the early tender results of its previously announced series of tender offers (the “Tender ...
Rite Aid's (RAD) Q1 results gain from higher sales of non-COVID-19 prescriptions and continued momentum at Elixir. Management raises its revenue guidance for fiscal 2023.
Rite Aid CEO Heyward Donigan: We are back to our transformation plan
Rite Aid CEO Heyward Donigan joins CNBC's 'Squawk Box' to break down the company's latest quarterly earnings report, which beat Wall Street's estimates.
The pharmacy chain's earnings report was just what the doctor ordered.
Earnings: Darden Restaurants tops fourth-quarter revenue estimates, Rite Aid raises guidance
Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss quarterly earnings for Darden Restaurants and Rite Aid.
Rite Aid (RAD) stock is running higher Thursday morning after the company revealed its earnings report for the fiscal first quarter of 2023. The post Rite Aid (RAD) Stock Pops on Q1 Revenue Beat appeare...
Rite Aid (RAD) delivered earnings and revenue surprises of 14.29% and 5%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?
Rite Aid Corp (NYSE: RAD) shares are trading higher Thursday after the company announced better-than-expected financial results and raised full-year revenue guidance above analyst estimates. Rite Aid re...
Rite Aid Corp (NYSE: RAD) has reported Q1 FY23 sales of 6.01 billion, down 2.4% Y/Y, beating the consensus of $5.75 billion. The company reported an EPS loss of $(0.60) compared to an income of $0.38 a...
Rite Aid Corp. RAD, +6.17% shares rose 4.8% in Thursday premarket trading after the pharmacy retailer reported first-quarter revenue that beat expectations and raised its full-year guidance. Net loss to...
PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) today reported operating results for its first fiscal quarter ended May 28, 2022. “We continue to make strides on our journey to transform...
Scheduling for COVID-19 Vaccinations for Children Ages 3 and Over Now Available at Rite Aid and Bartell Drug locations
PHILADELPHIA--(BUSINESS WIRE)--Following FDA authorization and new CDC recommendations, select Rite Aid (NYSE: RAD) locations – including Bartell Drugs, owned by Rite Aid Corporation, will be providing ...
Strong underlying business and robust digital and retail growth are expected to aid Rite Aid (RAD) in Q1. Its Retail Pharmacy segment is likely to be a key contributor despite supply headwinds.
CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) announced today the commencement of a series of tender offers to purchase for cash certain of its outstand...